Cardinal Health, Inc.

Informe acción NYSE:CAH

Capitalización de mercado: US$23.7b

Cardinal Health Dirección

Dirección controles de criterios 0/4

El CEO de Cardinal Health's es Jason Hollar , nombrado en Sep 2022, tiene una permanencia de 1.58 años. compensación anual total es $18.78M, compuesta por 6.6% salario y 93.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.018% de las acciones de la empresa, por valor de $4.67M. La antigüedad media del equipo directivo y de la junta directiva es de 1.6 años y 2.6 años, respectivamente.

Información clave

Jason Hollar

Chief Executive Officer (CEO)

US$18.8m

Compensación total

Porcentaje del salario del CEO6.6%
Permanencia del CEO1.7yrs
Participación del CEO0.02%
Permanencia media de la dirección1.7yrs
Promedio de permanencia en la Junta Directiva2.7yrs

Actualizaciones recientes de la dirección

Recent updates

Cardinal Health Q3 Earnings: Undervalued On Strong Guidance

May 03

Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Apr 14
Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Mar 09
Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration

Feb 20

Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Feb 03
Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues

Dec 28
Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues

Cardinal Health Is Setting Up For A Great 2024

Dec 21

Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Nov 03
Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity

Oct 13

Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation

Aug 07

Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue

Aug 05
Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue

An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued

Jul 14
An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued

Cardinal Health: Not A Long-Term Investment

May 24

The Return Trends At Cardinal Health (NYSE:CAH) Look Promising

Apr 17
The Return Trends At Cardinal Health (NYSE:CAH) Look Promising

Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price

Mar 30
Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price

Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)

Feb 21

Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957

Feb 16
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957

Cardinal Health declares $0.4957 dividend

Feb 10

Cardinal Health FQ2 2023 Earnings Preview

Feb 01

Cardinal Health partners with Palantir for data-driven supply chain support

Jan 26

Cardinal Health Is A Tempting Healthcare Income Play

Dec 28

Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957

Dec 20
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957

Aaron Alt is the new finance chief at Cardinal health

Dec 19

Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?

Dec 14
Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?

Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Nov 16
Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment

Nov 14

Cardinal Health rises on Q1 earnings beat

Nov 04

Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term

Oct 10

Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Sep 29
Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Cardinal Health: Aristocrat Heading For A Makeover

Sep 26

PayrHealth to collaborate with Cardinal Health

Sep 15

Cardinal Health in pact with activist investor Elliot for value creation measures

Sep 06

Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957

Sep 01
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957

Activist interest in Cardinal Health could unlock value, improve margins - Morgan Stanley

Aug 16

Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?

Aug 15
Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jason Hollar en comparación con los beneficios de Cardinal Health?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

US$552m

Dec 31 2023n/an/a

US$639m

Sep 30 2023n/an/a

US$156m

Jun 30 2023US$19mUS$1m

US$261m

Mar 31 2023n/an/a

US$463m

Dec 31 2022n/an/a

-US$1b

Sep 30 2022n/an/a

-US$1b

Jun 30 2022US$4mUS$729k

-US$933m

Mar 31 2022n/an/a

-US$955m

Dec 31 2021n/an/a

US$555m

Sep 30 2021n/an/a

US$1b

Jun 30 2021US$4mUS$700k

US$611m

Mar 31 2021n/an/a

US$1b

Dec 31 2020n/an/a

US$1b

Sep 30 2020n/an/a

US$973m

Jun 30 2020US$4mUS$124k

-US$4b

Compensación vs. Mercado: La compensación total de Jason($USD18.78M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD13.51M).

Compensación vs. Ingresos: La compensación de Jason ha aumentado más de un 20% en el último año.


CEO

Jason Hollar (50 yo)

1.7yrs

Permanencia

US$18,776,433

Compensación

Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Jason Hollar
CEO & Director1.7yrsUS$18.78m0.018%
$ 4.4m
Aaron Alt
Chief Financial Officer1.3yrsUS$6.00m0.00095%
$ 225.5k
Jessica Mayer
Chief Legal & Compliance Officer5.2yrsUS$4.40m0.016%
$ 3.7m
Stephen Mason
Chief Executive Officer of Medical Segment4.8yrsUS$4.42m0.0023%
$ 541.1k
Deborah Weitzman
Chief Executive Officer of Pharmaceutical Segment1.7yrsUS$4.07m0.014%
$ 3.4m
Patricia English
Senior Vice President1.3yrsUS$1.26m0.0020%
$ 481.8k
Mary Scherer
Senior VP & Chief Accounting Officer1.7yrssin datos0.0043%
$ 1.0m
Michelle Greene
Executive VP1.8yrssin datos0.0080%
$ 1.9m
Matt Sims
Vice President of Investor Relationsno datasin datossin datos
Ola Snow
Chief Human Resources Officer5.6yrssin datos0.010%
$ 2.4m
Craig Cowman
Executive Vice President of Strategic Sourcing & Manufacturer Servicesno datasin datossin datos
Ben Brinker
President of Global Products & Supply Chain3.2yrssin datossin datos

1.7yrs

Permanencia media

51.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CAH no se considera experimentado ( 1.6 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Jason Hollar
CEO & Director1.8yrsUS$18.78m0.018%
$ 4.4m
Gregory Kenny
Independent Non-Executive Chairman16.8yrsUS$553.58k0%
$ 0
Christine Ann Mundkur
Independent Director1.7yrsUS$310.03k0%
$ 0
Patricia Hemingway Hall
Independent Director10.7yrsUS$320.03k0.0045%
$ 1.1m
David Evans
Independent Director3.8yrsUS$302.03k0%
$ 0
Sheri Edison
Independent Director3.7yrsUS$319.95k0.0017%
$ 396.3k
Nancy Killefer
Independent Director8.7yrsUS$300.03k0%
$ 0
Akhil Johri
Independent Director6.3yrsUS$325.03k0%
$ 0
Sujatha Chandrasekaran
Independent Director1.7yrsUS$310.03k0%
$ 0
Steven Barg
Independent Director1.7yrsUS$310.03k0.00019%
$ 45.1k
Robert Azelby
Independent Directorless than a yearsin datossin datos
Michelle Brennan
Independent Director1.7yrsUS$310.03k0.00023%
$ 54.6k

2.7yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: La junta directiva de CAH no se considera experimentada (2.6 años de permanencia promedio), lo que sugiere una nueva junta directiva.